CD79A产品信息
英文名称:B-cell antigen receptor complex-associated protein alpha chain
中文名称:B细胞抗原受体复合体相关蛋白α链
靶点别称:CD79A,Ig-alpha
物种:Human/Cynomolgus
属性:Protein
标记:Unconjugated
内毒素(Endotoxin)
Less than 1.0 EU per μg by the LAL method.
纯度(Purity)
>90% as determined by SDS-PAGE.
制剂(Formulation)
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
重构方法(Reconstitution)
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存储(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.
![1.jpg 1.jpg](/SupplyImg/2024-04-26/6384974824522450857492881.jpg)
CD79A分子背景
B细胞抗原受体复合物相关蛋白α链(CD79a),也称为CD79α、IgM-α、Ig-α和mb-1,是前B细胞受体(preBCR)的信号成分。共价连接的CD79a和CD79b异二聚体与膜免疫球蛋白(mIg)以非共价结合的方式构成B细胞抗原受体(BCR)。CD79a需要与CD79b协同作用,以启动由抗原与B细胞抗原受体复合物(BCR)结合激活的信号转导级联,导致复合物内化、运输到晚期内体和抗原呈递。CD79a也是BCR表面表达以及前B细胞和前B细胞有效分化所必需的。
![通用.jpg 通用.jpg](/SupplyImg/2024-04-26/6384974825761945116139666.jpg)
关键字: CD79A;CD79A蛋白;CD79A重组蛋白;ACRO;百普赛斯;
百普赛斯集团ACROBiosystems Group(股票代码:301080)是成立于2010年的跨国生物科技公司,是为全球生物医药、健康产业领域提供关键生物试剂产品及解决方案的行业平台型基石企业。2021年在创业板上市。百普赛斯集团业务遍布全球,横跨亚洲、北美洲、欧洲,在中国、美国、瑞士等12个城市设有办公室、研发中心及生产基地。目前累计服务客户超6000家,与全球Top 20医药企业均建立了长期、稳定的合作伙伴关系。集团旗下拥有品牌ACROBiosystems百普赛斯、bioSeedin柏思荟、Condense Capital垦拓资本和ACRODiagnostics百斯医学等。